India Microfluidics Market Overview, 2029

Opening the world of microfluidics in India, it is fast growing and changing the face of scientific research and diagnostics. This technology deals with the manipulation of small volumes of fluids using channels with dimensions of tens to hundreds of micrometers. Then, there is the potential to be at the core of developing the so-called lab-on-a-chip devices, which integrate onto a single chip several laboratory functions. These systems are quite important in areas like medical diagnostics, pharmaceuticals, and biotechnological applications, and environmental monitoring, where fluids have to be manipulated and analyzed at a very minute scale with precision. Drivers of growth for the India microfluidics market would come from healthcare and diagnostics alone, wherein the demand for better-developed diagnostic tools is higher due to contemporary chronic disorders like diabetes, heart diseases, and cancer. Moreover, it is also fueled by the demand for point-of-care diagnostics, which allows quick and accurate tests right at the patient's location. Microfluidics can be used in support of the pharmaceutical and biotechnology industries through enabling high-throughput screening and drug discovery, thus shaping a more efficient and cost-effective drug development process. Efforts in enhancing lab-on-a-chip technology and integration with other technologies, such as 3D printing and artificial intelligence, further extend what microfluidics is able to do. This, in addition to supportive government initiatives, such as funding of studies and development and linked regulatory policies for medical technologies, is driving the market growth. The market consists of both local and global players. Recognized global companies, namely Thermo Fisher Scientific Inc., PerkinElmer Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., and Agilent Technologies, Inc., have a wide array of microfluidics products for research and diagnostics. Local players, such as Molbio Diagnostics Pvt. Ltd., known for its Truenat platform, Achira Labs Pvt. Ltd., engaged in rapid diagnostics, and Bigtec Labs dealing with portable diagnostic devices, contributed significantly to the segment. According to the research report "India Microfluidics Market Overview, 2029," published by Bonafide Research, the India Microfluidics market is anticipated to add to more than USD 690 Million by 2024–29. Despite the potential, a number of challenges riddle the microfluidics market in India. One such challenge is that the high cost of development and assembly could lower the chances of adoption in cost-sensitive markets. The development and operation of microfluidic systems require specialized knowledge and technical expertise, which again is a challenge to the ordinary people. In addition, stringent regulatory requirements for Class III medical devices controlling the development, manufacturing, and selling of these devices might delay product approvals and a subsequent entry into the market. This impacts the time it takes for a new product to reach the market. There are huge opportunities available in the India microfluidics market, mainly related to point-of-care testing and personalized medicine. Microfluidic devices facilitate rapid and accurate testing in remote and rural areas without expensive laboratory infrastructure and trained personnel. Personalised Medicine—differentiated treatment based on the genetic profile of a patient—will be another upper driver of microfluidics in drug development and diagnostics. Increased investment in research and development of new applications of microfluidics in tissue engineering and regenerative medicine-related uses therefore opens up further opportunities. This is expected for collaborations between academic institutions, research organizations, and industries to boost technological changes and, in the end, drive market growth. BIRAC is a Public Sector Enterprise under the Department of Biotechnology, Government of India, that fosters innovation research in biotechnology. It funds, mentors, and provides incubation facilities to startups and SMEs working on microfluidic technologies in biotechnology. Start-up India Initiative is started by the Government of India, this initiative has been launched to incentivize innovation and create an enabling ecosystem for start-ups working in sectors like health and biotechnology. It also provides financial support, tax benefits, and easier regulatory compliance to start-ups working on innovative technologies like microfluidics. National Bio-pharma Mission(NBM) is an industry–academia collaborative mission that accelerates the developing biopharmaceuticals in India. Funds and support for research and development in works related to biopharmaceuticals, including microfluidic-based diagnostic tools and drug discovery platforms. The India microfluidics market is likely to grow at a strong pace in the future. This could be ascribed to the increasing demand for advanced diagnostic technologies, rising chronic diseases in the country, and technological advancements. Policies by the government to encourage the same and the entry of local players are likely to boost growth further

India's semiconductor manufacturing ecosystem is opening up, yet in the background, MEMS devices have become key components in several industries. INFAB devices are well suited for healthcare, automotive, aerospace, and consumer electronics due to their high precision, accuracy, and reliability. Individually, MEMS devices in microfluidics lend themselves particularly to drug delivery, diagnostics, and patient monitoring. These comprises of minute passages in which the fluid flows or is handled. Achira Labs is a technology company based in Bangalore and is developing analytical medical diagnostic platforms using a microfluidic approach. The first platform is the lab-on-chip concept that includes a microfluidics chip and a reader. This platform is directed mainly toward tests performed in big analyzers, like ELISA immunoassays, providing a point-of-care approach to the diagnosis of disorders associated with the thyroid or female infertility. The first such product, which was able to detect various levels of hormones in female infertility, is set to mark this year's markets. Achira Labs previously had received a three-year $1 million grant at Canada's Grand Challenges competition for its idea of a fabric diagnostic chip. Dr Ram Chepyala and Prof Siddhartha Panda from the Indian Institute of Technology Kanpur have designed a portable microfluidic chip holder, which has multiple ports on a sliding port holder, and patented it in India. Material-wise, the India microfluidics market shows huge diversified use of materials for the fabrication of microfluidic devices. The segmentation into four primary categories of materials takes in polymer, glass, silicon, and other materials like paper-based, ceramic-based, hydrogel, and metal-based microfluidics. Polymer-based microfluidics dominates due to cost, ease of fabrication, and biocompatibility. The most used polymers in this sector include PDMS, PMMA, and COC. An example would be when Indian researchers developed PDMS-based microfluidic chips for malaria diagnosis, proving time and time again the potential of polymer-based microfluidics in healthcare applications. Although less popular than polymers due to their higher production costs, glass-based microfluidics offer excellent optical transparency, chemical resistance, and surface smoothness, which shapes them for high-precision and high-sensitivity applications and is used in developing lab-on-a-chip devices. For example, single-cell analysis glass-based microfluidic devices have been developed by Indian scientists. The other, less common, silicon-based microfluidics offer better mechanical properties and are mainly applied in highly durable and temperature-resistant applications. Normally, they can be fabricated with MEMS technology. For example, silicon-based microfluidic devices are utilized in the DRDO of India for different defense applications. Other NEXT-generation microfluidics in the pipeline include paper-based, ceramic-based, hydrogel, and metal-based microfluidics. Of these, paper-based microfluidics has generated a lot of interest recently owing to its low cost, portability, and user-friendly interface that makes the technique very befitting for point-of-care diagnostics in resource-limited settings. For example, there is the development of paper-based microfluidic devices to diagnose diseases in rural India. The microfluidics market can be segmented into applications with different characteristics and growth drivers. One of the most prominent would be point-of-care diagnostics, driven by growing demand for rapid testing on-site within healthcare settings across the country. This application area becomes relevant specifically because India has a huge population and hence requires diagnostic accessibility solutions at the urban and rural levels. Microfluidic technologies support couplings of precise control needed for drug release and achieve targeted delivery that can actually revolutionize treatments for a bevy of diseases prevalent in the country. Adoption of microfluidic technologies in the pharmaceutical and biotechnology research sector in India is using them for drug discovery, genomics, and proteomics studies, which accelerates the pace of research and development in these fields. Another fast-growing area of application is in vitro diagnostics, where microfluidic devices have been applied in laboratory tests such as immunoassays, with their attendant advantages like small volumes of sample usage and fast results. The category "Others" includes, among many others, applications in environmental testing, where microfluidic devices are being applied to water quality monitoring and pollutant detection, in addition to industrial applications mainly in process control and quality assurance during manufacturing. The major primary end-users of microfluidic technologies in India are hospitals and diagnostic centers. These devices aid in diagnostics, due to their preciseness, swiftness, and cost-effectiveness. Microfluidic-based devices, like lab-on-a-chip and point-of-care test kits, aid in fast and accurate diagnosis of diseases. For example, in infectious diseases like tuberculosis, malaria, and COVID-19, the application of microfluidic devices is very huge since it gives rapid results with very small amounts of sample volumes. Diagnostics at the All India Institute of Medical Sciences in New Delhi implement microfluidic devices from blood tests to molecular diagnostics, which becomes very important in the rural and remote areas where conventional laboratory facilities are not available. This offers timely medical intervention and better patient outcomes. Pharmaceutical and biotechnology companies in India apply microfluidic technologies in drug discovery, development, and manufacturing processes. Such devices will accomplish high-throughput screening, drug formulation, and toxicological studies by bringing down time and cost. For instance, Dr. Reddy's Laboratories and Biocon apply microfluidic platforms to rapidly screen potential drug candidates for efficacy and safety. A very vital application of microfluidic devices is in setting up personalized medicine, where targeted and precise drug delivery systems are put in place. OOC devices simulate human organ functions and are used for preclinical testing. This can yield much more accurate models of drug efficacy and toxicity, which will reduce the use of animals in the final stages of preclinical drug testing. These applications make the pipeline of drug development much quicker and increase the effectiveness of research and production in pharmaceuticals. Academic and research institutes in India are developing innovations and applications in microfluidic technology at the forefront. In institutions like IITs and NIPER, a lot of research goes on in the area of microfluidics. New microfluidic devices and applications come up from these institutes that contribute to various fields with technological advancements in genomics, protomics, and cell biology. IIT Bombay has developed microfluidic chips for the detection and analysis of cancer cells, while other institutions like NIPER are currently engaged in developing microfluidic systems focused on drug delivery and diagnostics. This academia-industry collaboration leads to innovation, which helps in commercializing these novel microfluidic technologies. These research projects develop the skilled manpower working on the area of microfluidics, thus driving the market growth. Major end-users of microfluidic technologies in India include the contract research organization and industrial users. CROs like Syngene International and GVK BIO use microfluidic devices for research and development projects done on behalf of pharmaceutical and biotechnology companies to undertake high-throughput screening for biomarker discovery, environmental monitoring, and ensuring efficient and cost-effective research results. Microfluidic devices become very critical in analytical tasks for any industrial user targeting environmental monitoring, food safety, and any chemical analysis. Microliter devices help in the quality assurance of water through the monitoring of contaminants and pathogens, thus adhering to environmental regulations. Versatility and precision make microfluidic technologies invaluable tools in any number of industrial applications that go on to improve process efficiency and product quality. Considered in this report • Historic year: 2018 • Base year: 2023 • Estimated year: 2024 • Forecast year: 2029

Aspects covered in this report • Microfluids market Outlook with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Product Type • Microfluidic-based Devices • Microfluidic Components (Microfluidic Chips, Micro Pumps, Microneedles and other Mocrofluids Components Type) By Material • Polymer • Glass • Silicon • Other Materials (Paper-based microfluidics, Ceramic-based microfluidics, Hydrogels, Metal-based microfluidics) By Application • Point-of-care diagnostics • Drug delivery systems • Pharmaceutical and biotechnology research • In vitro diagnostics • Others (e.g., environmental testing, industrial applications) By End User • Hospitals and diagnostic centers • Pharmaceutical and biotechnology companies • Academic and research institutes • Others (e.g., contract research organizations, industrial users) The approach of the report: This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources. Intended audience This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the Microfluids industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.